Epiyangambin

Cat. No.: IBDI-430854

Epiyangambin is a competitive platelet activating factor receptor (PAF) antagonist that dose-dependently inhibits PAF-induced platelet aggregation. Epiyangambin also inhibits the growth of human colon cancer cells (SW480 cells).

Product Details

Target	Platelet-activating Factor Receptor (PAFR)
Molecular Weight	446.49
SMILES	COC1=C(OC)C(OC)=CC([[email protected]]2OC[[email protected]]3([H])[[email protected]](C4=CC(OC)=C(OC)C(OC)=C4)OC[[email protected]@]32[H])=C1
Structure Classification	Phenylpropanoids>Lignans

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.